Sobell Department of Motor Neuroscience and Movement Disorders, University College London (UCL) Institute of Neurology, Queen Square, London, UK.
Department of Neurology, University Hospital Zurich, Zurich, Switzerland.
Mov Disord. 2018 Jan;33(1):146-155. doi: 10.1002/mds.27174. Epub 2017 Sep 13.
Mitochondrial disease can present as a movement disorder. Data on this entity's epidemiology, genetics, and underlying pathophysiology, however, is scarce.
The objective of this study was to describe the clinical, genetic, and volumetric imaging data from patients with mitochondrial disease who presented with movement disorders.
In this retrospective analysis of all genetically confirmed mitochondrial disease cases from three centers (n = 50), the prevalence and clinical presentation of video-documented movement disorders was assessed. Voxel-based morphometry from high-resolution MRI was employed to compare cerebral and cerebellar gray matter volume between mitochondrial disease patients with and without movement disorders and healthy controls.
Of the 50 (30%) patients with genetically confirmed mitochondrial disease, 15 presented with hypokinesia (parkinsonism 3/15), hyperkinesia (dystonia 5/15, myoclonus 3/15, chorea 2/15), and ataxia (3/15). In 3 patients, mitochondrial disease presented as adult-onset isolated dystonia. In comparison to healthy controls and mitochondrial disease patients without movement disorders, patients with hypo- and hyperkinetic movement disorders had significantly more cerebellar atrophy and an atrophy pattern predominantly involving cerebellar lobules VI and VII.
This series provides clinical, genetic, volumetric imaging, and histologic data that indicate major involvement of the cerebellum in mitochondrial disease when it presents with hyper- and hypokinetic movement disorders. As a working hypothesis addressing the particular vulnerability of the cerebellum to energy deficiency, this adds substantially to the pathophysiological understanding of movement disorders in mitochondrial disease. Furthermore, it provides evidence that mitochondrial disease can present as adult-onset isolated dystonia. © 2017 International Parkinson and Movement Disorder Society.
线粒体疾病可表现为运动障碍。然而,关于这种疾病的流行病学、遗传学和潜在病理生理学的数据却很少。
本研究旨在描述以运动障碍为表现的线粒体疾病患者的临床、遗传和容积成像数据。
在对来自三个中心的所有经基因证实的线粒体疾病病例(n=50)的回顾性分析中,评估了视频记录的运动障碍的患病率和临床表现。采用基于体素的形态计量学方法,比较了有和无运动障碍的线粒体疾病患者与健康对照组之间的大脑和小脑灰质体积。
在 50 名(30%)经基因证实的线粒体疾病患者中,15 名患者出现运动减少(帕金森病 3/15)、运动过度(肌张力障碍 5/15、肌阵挛 3/15、舞蹈症 2/15)和共济失调(3/15)。3 名患者表现为成人起病的孤立性肌张力障碍。与健康对照组和无运动障碍的线粒体疾病患者相比,出现低动力和高动力运动障碍的患者小脑萎缩更明显,且萎缩模式主要累及小脑叶 VI 和 VII。
本研究系列提供了临床、遗传、容积成像和组织学数据,表明当线粒体疾病伴有快动和慢动运动障碍时,小脑会受到严重影响。作为一个针对小脑对能量缺乏特别脆弱的工作假说,这大大增加了对线粒体疾病运动障碍的病理生理学理解。此外,它还提供了证据表明线粒体疾病可表现为成人起病的孤立性肌张力障碍。